Hamelin Gold Limited

HMG

Hamelin Gold Ltd. engages in the business of mineral exploration and resource development. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2021-11-05. The firm has a landholding of approximately 2,277 square kilometers (km2) in the Tanami Gold Province in Western Australia. The province is prospective for gold deposits and hosts Newmont’s Tier 1 Callie Operations in the Northern Territory. The Company’s West Tanami project has approximately 100 kilometers (km) of strike along the Trans-Tanami structural corridor that hosts Newmont’s giant +14Moz Callie gold deposit in the Northern Territory; and open, gold intersections beneath shallow cover, significant multi-kilometer scale geochemical anomalies and a portfolio of untested geophysical targets in a Tier 1 jurisdiction.

Hiremii Limited

HMI

Hiremii Ltd. is a technology-driven recruitment and full service labour hire company. The company is headquartered in Perth, Western Australia. The company went IPO on 2021-05-11. The firm has two business components, such as Hiremii Technology and Inverse Group Pty Ltd (Inverse Group). Hiremii Technology is a cloud-based platform, which uses machine learning and artificial intelligence to remove the tedious manual tasks associated with the recruitment and onboarding process, pre-vetting and shortlisting candidates based on the employer specific requirements. The Inverse Group is a recruitment business that provides specialist white collar recruitment services to the energy, resources, and technology sectors. The company is developing a shortlisting tool that matches candidates on its cloud-based platform. Utilizing artificial intelligence (AI) technology, it can parse candidate curriculum vitae (CVs) and match the candidate against a client's job scope.

Heramed Limited

HMD

HeraMED Ltd. engages in the development and production of pregnancy monitoring solutions for home and professional use. The company offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The firm also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.